Skip to Content

Bristol-Myers Squibb

Bristol-Myers Squibb, one of the world’s largest pharmaceutical companies, arose out of a 1989 merger and today focuses on the manufacture of prescription medicines for the treatment of cancer, diabetes, cardiovascular disease, and psychiatric disorders. In 2021, the company took part in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, a collaboration with the National Institutes of Health, whose goal was to develop a national strategy for a coordinated COVID-19 research response. As part of the initiative, Bristol-Myers Squibb donated several of its products to trials aimed at assessing potential treatments for patients with COVID-19.
Regis Duvignau—Reuters
Lists ranking Bristol-Myers Squibb
World’s 25 Best Workplaces - 2022Organizations on this annual list positively impac...READ MOREview in list
Global 500 - 2022Aggregate sales hit $37.8 trillion last year—an in...READ MOREview in list
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MOREview in list
Fortune Modern Board 25 - 2022Fortune collaborated with the Diligent Institute t...READ MOREview in list
World’s Most Admired Companies - 2022Just as it dominates our economy, Big Tech now dom...READ MOREview in list